Central European Journal of Immunology
eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2025
vol. 50
 
Share:
Share:
Review paper

Innate immunosenescence and sepsis in the elderly: mechanisms and innate immune modulation strategies

Danfeng Zhang
1
,
Jing Cheng
1
,
Donghua Cao
1
,
Kai Sheng
1

  1. Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
Cent Eur J Immunol 2025; 50 (1): 3-10
Online publish date: 2025/05/05
Article file
Get citation
 
PlumX metrics:
 

Introduction

Sepsis is a life-threatening condition characterized by a dysregulated host response to infection, leading to organ dysfunction [1]. It accounts for 20% of global deaths [2], posing a significant public health issue, particularly in adults aged 70 and above. The pathogenesis of sepsis involves complex interactions between immune and adaptive responses, endothelial dysfunction, and autophagy [3]. Age is typically considered an independent risk factor for both mortality and morbidity, with the incidence and death rates increasing significantly with age [4, 5]. A nationwide study on sepsis in Taiwan revealed that the incidence of sepsis in the oldest elderly (≥ 85 years) was 31 times higher than in adults (18-64 years) and three times higher than in the elderly (65-84 years) [6].

The high mortality rate in elderly sepsis patients is linked not only to infection severity but also to comorbidities, atypical symptoms, and a higher risk of multi-organ failure [7]. Immunosenescence, the age-related decline in immune function, is a critical factor in immune system impairment and a key risk factor for sepsis severity in the elderly [8]. Understanding innate immunosenescence mechanisms can inform more effective clinical strategies for elderly sepsis patients.

Characteristics of sepsis in the elderly

Infections are common in the elderly, leading to increased hospitalization and mortality, especially in those aged 85 and older. Lower respiratory tract infections and urinary tract infections (UTIs) are predominant [9]. A retrospective study indicated that among 308 elderly patients, respiratory tract infections accounted for 49.7%, UTIs for 33.8%, bloodstream infections for 21.1%, and surgical site infections for 4.9% [10]. Due to the presence of comorbidities, impaired immune function, sarcopenia, reduced physiological reserve associated with aging, malnutrition, and polypharmacy, infections in the elderly are particularly prone to progress to sepsis [11].

The diagnosis of sepsis in the elderly is challenging due to atypical symptoms, age-related changes, and comorbidities. Additionally, aging increases the risk of sudden deterioration into septic shock, necessitating rapid treatment, which further complicates diagnosis and management [12]. Typical clinical markers of infection, such as C-reactive protein (CRP) and procalcitonin, lack sensitivity and specificity in this age group, leading to delays in treatment [13-15].

Immunosenescence impairs both cell-mediated and humoral immune responses, worsening prognosis and increasing mortality in elderly sepsis patients [16]. Immunosenescence contributes to post-sepsis organ damage [17]. Specific pathophysiological changes during aging, including immunosenescence, lead to higher mortality rates in elderly sepsis patients [18]. Moreover, a reduction in immunocompetent B cells and impaired humoral immunity are critical changes in elderly sepsis patients, increasing their susceptibility to secondary infections [19]. Differences in immune responses to sepsis between neonates and the elderly, particularly at the leukocyte transcriptome level, further contribute to the increased mortality in these groups [20]. Additionally, the decline in immune function in elderly patients, including defects in T and B cell functions, alterations in cytokine and chemokine signaling networks, and a more pronounced pro-coagulant state, play significant roles in their increased susceptibility to severe diseases.

Innate immune system and its aging mechanisms

The aging of the innate immune system is characterized by a decrease in certain immune cells, changes in cytokine activity, and an imbalance between pro-inflammatory and anti-inflammatory responses [21]. Although the clinical significance of immune aging is still debated [22], it is clear that it significantly impacts the health of the elderly, leading to higher infection risks and reduced responses to vaccinations [23].

Mechanisms of neutrophil aging and their impact

Neutrophils, the most abundant white blood cells, defend against bacterial and fungal infections. Although aging does not affect the total number of circulating neutrophils, their functional aspects decline with age [24].

In the elderly, neutrophil responsiveness to chemotactic factors decreases, reducing migration efficiency to infection sites and increasing infection spread risk [25, 26]. Neutrophils release neutrophil extracellular traps (NETs) to capture and immobilize pathogens, but NETs from elderly individuals have larger DNA fiber sizes, resulting in lower bactericidal activity and reduced stimulation of HaCaT cell proliferation. Additionally, neutrophils from elderly patients show an increased mitochondrial response, enhancing NET formation, which contributes to vascular endothelial damage and thrombosis [27]. Elderly patients’ neutrophils also display a deficient response to TREM1, leading to reduced cytokine, chemokine, and reactive oxygen species (ROS) production, which increases susceptibility to microbial infections [28].

Mechanisms and effects of aging on monocytes/macrophages

Monocytes differentiate into macrophages, crucial for immune defense and tissue repair. With aging, the functions of monocytes and macrophages undergo significant changes:

In elderly individuals, the number of macrophages remains relatively stable, but their initial response to microorganisms and other inflammatory stimuli decreases. Van Duin et al. observed that macrophages isolated from aged mice showed a reduced response to TLR-1, TLR-2, and TLR-4 stimulation, with decreased activation of pro-inflammatory signaling pathways such as NF-κB, p38, and JNK, leading to reduced production of tumor necrosis factor α (TNF-α), interleukin (IL)-1β, and IL-6 [29-31]. Additionally, Li et al. found that alveolar macrophages isolated from aged mice exhibited decreased Rac1 mRNA expression, resulting in lower levels of Rac1 GTP and Arp2/3 activation, reduced downstream F-actin polymerization, impaired filopodia formation, and decreased MARCO surface expression, severely affecting macrophage phagocytosis [32]. Furthermore, reduced HLA-DR expression during aging diminishes the ability of macrophages to present antigens to CD4+ T cells [33], and their ability to clear apoptotic cells also declines with age. This not only weakens their effectiveness in eliminating infections but also leads to excessive inflammation and tissue damage [34, 35].

Interferon γ (IFN-γ) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are major activators of monocytes and macrophages [36]. In sepsis patients, recombinant IFN-γ or GM-CSF treatment has been shown to enhance phagocytosis and HLA-DR expression in monocytes and macrophages, improving survival rates [37, 38]. Since aging and sepsis both reduce HLA-DR expression, and phagocytic function, they may have a cumulative inhibitory effect in elderly sepsis patients. Therefore, IFN-γ and GM-CSF could be potential therapeutic alternatives to reverse monocyte or macrophage dysfunction in elderly sepsis patients, thereby improving survival rates.

Mechanisms and effects of aging on natural killer cells

Most studies indicate that the number of natural killer (NK) cells, crucial for innate immune defense, remains stable or slightly elevated during aging [39, 40]. However, with age, there is a decrease in the subset of cytotoxic NK cells (CD56dim NK cells) and an increase in the subset of regulatory NK cells (CD56bright NK cells). This shift can negatively impact immune responses against infections and malignancies [41, 42].

Functionally, NK cells in the elderly exhibit normal or increased production of IFN-γ but have reduced cytotoxicity [39, 43]. This reduction in cytotoxicity may be due to the impaired secretion of perforin in the immune synapse, which is critical for the granule exocytosis (perforin/granzyme) pathway that NK cells use to induce apoptosis in target cells [44]. The defect in perforin secretion contributes to the decrease in NK cell cytotoxicity (NKCC) observed with physiological aging [43]. Additionally, studies have shown that the reduced cytotoxicity in elderly NK cells is associated with significantly decreased activity of acid phosphatase, an enzyme crucial for the maintenance of NK cell cytotoxic function by regulating signal transduction pathways originating from killer cell immunoglobulin-like receptors (KIRs) [45-47].

Aging mechanisms and effects on dendritic cells

Dendritic cells (DCs) initiate and regulate adaptive immune responses. With aging, the number of DCs slightly increases [48]. However, aged DCs exhibit impairments in migration, antigen uptake, pinocytosis, and phagocytosis [49].

CCR7 and CXCR4 are key regulators of DC migration, and their expression and function decline with age [50]. Additionally, the CXCL12-CXCR4 axis, another critical pathway for DC migration, is affected by aging [51]. Agrawal et al. observed that monocyte-derived DCs (MODCs) in elderly individuals have reduced antigen capture capacity, potentially due to impaired AKT kinase activation [52]. Aged DCs exhibit a pro-inflammatory phenotype characterized by increased basal secretion of pro-inflammatory cytokines such as IL-6 and TNF-α, which may be linked to the senescence-associated secretory phenotype, a hallmark of immunosenescence [53-55]. Furthermore, Li et al. found that CD8α+ DCs in elderly mice show poor upregulation of co-stimulatory molecules for MHC-II and CD40, leading to a less effective T-cell priming environment [56].

Immunosenescence and susceptibility to sepsis

Immunosenescence involves the functional decline and altered signaling pathways of various immune cells. These changes increase susceptibility to infections in the elderly and impair the initiation and maintenance of effective immune responses during infections, leading to higher incidence and mortality of sepsis. A thorough understanding of these mechanisms is crucial for developing effective clinical management strategies to improve outcomes for elderly sepsis patients.

Neutrophil aging and susceptibility to sepsis

Neutrophil aging significantly impacts their function, making elderly individuals more susceptible to sepsis [57]. The role of neutrophils in sepsis is complex. Nacionales et al. observed that aged septic mice exhibit impaired neutrophil migration and antibacterial activity, leading to an inadequate response to infection [58]. This is likely due to reduced expression of the surface receptors CXCR1 and CXCR2 [59]. Additionally, aged mice show an ineffective bone marrow response to sepsis, further increasing susceptibility [60].

Elderly individuals often have an excess of NETs with compromised functionality, resulting in organ dysfunction and severe tissue damage associated with sepsis [61]. The reduced accuracy of neutrophil migration and increased formation of NETs prolong the immunosuppressive phase, contributing to higher susceptibility and mortality in elderly patients and septic animals [62].

Neutrophils can also act as antigen-presenting cells, bridging innate and adaptive immune responses by activating T cells [19]. However, in elderly septic patients, an immunosuppressive subset of neutrophils emerges, characterized by the production of large amounts of IL-10, which further suppresses T cell proliferation and function [63, 64].

Monocyte/macrophage aging and susceptibility to sepsis

Increased susceptibility to sepsis in aged mice can be partly attributed to reduced phagocytic activity and immune resolution of monocytes and macrophages, along with increased expression of aging-related markers and elevated production of inflammatory cytokines [65]. This heightened susceptibility is exacerbated by local inflammatory responses in aged mice [66].

Rondina et al. observed that elderly septic patients exhibited enhanced platelet-monocyte aggregate (PMA) formation, along with increased production of the pro-inflammatory cytokines IL-6 and IL-8 by monocytes, both significantly correlated with 28-day mortality [67]. Enhanced PMA formation has been shown to amplify inflammatory and thrombotic responses in elderly septic patients, potentially leading to an impaired immune response, organ failure, disability, and death [68]. Furthermore, aging impairs the phagocytic ability of alveolar macrophages, increasing the susceptibility of elderly individuals to sepsis [32]. During sepsis, reduced expression of HLA-DR isoforms in bone marrow diminishes the antigen-presenting capacity of monocytes, further exacerbating immunosuppression and reducing pathogen-fighting ability [69].

NK cell aging and susceptibility to sepsis

Research indicates that NK cells undergo significant functional and phenotypic changes during aging, which may affect the susceptibility of elderly individuals to infections, particularly sepsis [70].

Aged NK cells exhibit reduced efficacy in combating bacterial and viral infections, mainly due to decreased expression of activating receptors such as NKp30 and NKp46, leading to diminished cytotoxicity at the single cell level [71]. Furthermore, IL-2-triggered signaling pathways are impaired in aged NK cells, along with decreased mitochondrial function and metabolic flexibility. These changes result in reduced NK cell effector functions and increased production of IFN-γ, which exacerbates tissue damage, potentially explaining the higher incidence of sepsis in the elderly [39, 43].

Activated NK cells require a transition from oxidative phosphorylation (OXPHOS) to aerobic glycolysis to maintain their effector functions [72, 73]. However, aged NK cells exhibit defects in this metabolic transition, leading to a higher incidence of sepsis in elderly patients [74]. This metabolic shift is also crucial for T cell effector functions [75]. The age-related decline in the ability to adapt to stress, including reduced reactive oxygen species production, may further increase the susceptibility of elderly individuals to sepsis [76].

Dendritic cell aging and susceptibility to sepsis

Studies comparing monocyte-derived myeloid dendritic cells (MDDCs) in elderly individuals to DCs in younger people have shown that although their phenotypes are similar, aged DCs exhibit reduced AKT phosphorylation. This suggests decreased activation of the PI3K pathway, which is crucial for phagocytosis and migration, and functions as a negative regulator of TLR signaling through p38 MAPK activation. This may explain the impaired innate immune function in elderly DCs [53].

Additionally, aged DCs display reduced capacity for antigen uptake through phagocytosis and endocytosis. The decreased expression and function of HLA-DR further impair antigen presentation, reducing the efficacy of adaptive immune responses and increasing susceptibility to secondary hospital infections [77].

The significant increase in TNF-α and IL-6 secretion induced by lipopolysaccharide (LPS) and single-stranded RNA in aged DCs affects T and B cell activities. This can lead to inappropriate immune activation or suppression, with excessive inflammatory responses causing systemic inflammatory response syndrome (SIRS), thus exacerbating sepsis progression.

Clinical management strategies

Managing sepsis in the elderly is challenging due to age-related changes, comorbidities, and institutionalization, often resulting in atypical infection presentations such as confusion, decreased appetite, and gait instability [78]. These atypical presentations lead to significant delays in the diagnosis and treatment of sepsis [68]. Therefore, management strategies must focus on early recognition and intervention [79]. Recent studies emphasize the importance of immunomodulatory treatments to improve prognosis and reduce mortality.

For neutrophil dysfunction, granulocyte colony-stimulating factor (G-CSF) can enhance neutrophil numbers and function, improving infection clearance and survival rates in elderly sepsis patients [80]. Targeting neutrophils through strategies such as A2A adenosine receptor activation can prevent their senescence and promote polarization from the N1 to N2 phenotype, thereby improving their function [81].

Another study indicated that statins can modulate age-related neutrophil function, enhancing their response to infections. A randomized, double-blind, placebo-controlled pilot study showed that high-dose simvastatin improved systemic neutrophil function (NETosis and chemotaxis), reduced systemic neutrophil elastase load, and improved Sequential Organ Failure Assessment (SOFA) scores in elderly patients with community-acquired pneumonia and sepsis (CAP+S) [82].

Regarding macrophages, GM-CSF can mediate high phagocytic capacity by regulating glycolysis and lipid metabolism and produce IL-10 under LPS stimulation [83]. GM-CSF also enhances mitochondrial turnover in macrophages by regulating fatty acid β-oxidation, tricarboxylic acid cycle activity, and ATP production [84]. Interferon γ- treated macrophages show increased colocalization with the autophagy molecule p62, increased autophagosome formation, and increased lysosomal transport, significantly reducing the bacterial burden compared to untreated macrophages [85].

Additionally, IL-15 and FLT3 ligand (FLT3L) have shown potential applications. Interleukin 15 can enhance the immunostimulatory properties of DCs, inducing strong CD8 T cell responses and higher NK cell proliferation [86]. It also effectively recruits immune effector cells such as CD8+ T cells, NK cells, and γδ T cells [87]. Interleukin 15 can enhance NK cell cytotoxicity by upregulating NKG2D and cytotoxic effector molecule expression and phosphorylating STAT1 and ERK1/2, contributing to effective anti-infection responses [88]. FLT3L, a DC growth factor, has been shown in mouse models to prevent the decline in post-sepsis T cell numbers and improve T cell function [89], suggesting potential for ameliorating sepsis-induced immunosuppression.

Strategies targeting immune cell functional changes, including enhancing metabolic activity and adjusting immune signaling pathways, can significantly improve monocyte function and infection response in elderly patients [90].

The intricate relationship between aging, immune function, and sepsis susceptibility is further elucidated in the following summary table (Table 1).

Table 1

Immune cell aging and modulation strategies in elderly patients with sepsis

Type of immune cellModulatorsFunctionsFuture prospects
NeutrophilsTREM1, G-CSFDecreased responsiveness to chemotactic factors, reduced efficiency in migrating to infection sitesDevelopment of new NET modulators to enhance bacterial clearance
Monocytes/macrophages IFN-γ, GM-CSF Reduced initial response to microbes, decreased activation of pro-inflammatory signaling pathways Use of IFN-γ and GM-CSF treatments to improve macrophage function and survival rates
Natural killer (NK) cellsPerforin, interleukin 2Reduced cytotoxicity, decreased perforin secretionEnhancement of NK cell cytotoxicity and anti-infection capabilities
Dendritic cellsCCR7, CXCR4, CXCL12Impairment in migration, antigen uptake, pinocytosis, and phagocytosisImprovement of DCs’ antigen presentation ability, enhancement of T-cell priming efficiency

Conclusions

This review explores the key mechanisms of innate immune aging in elderly sepsis and its impact on disease management. With aging, the functions of immune cells such as neutrophils, macrophages, NK cells, and dendritic cells decline, increasing susceptibility to sepsis and worsening disease severity and prognosis. These cellular senescence processes include reduced chemotaxis, impaired bactericidal activity, and altered cytokine and chemokine production, which collectively weaken the immune response to infections in the elderly.

Diminished innate immune function poses specific challenges in the clinical management of sepsis in the elderly, necessitating adjustments and optimizations to existing treatment protocols. Immunomodulatory strategies targeting the unique characteristics of immune aging in the elderly show promising potential for improving outcomes.

Future research must delve deeper into the detailed mechanisms of innate immune aging related to elderly sepsis and develop new diagnostic and therapeutic tools to better understand and manage this complex clinical issue. Particularly, validating these new immunomodulatory strategies in clinical trials will provide critical guidance for managing elderly sepsis patients. Through these efforts, we aim to offer more effective, personalized treatment plans for elderly sepsis patients, ultimately improving their prognosis and quality of life.

Funding

This research received no external funding.

Disclosures

Approval of the Bioethics Committee was not required.

Notes

[1] Conflicts of interest The authors declare no conflict of interest.

References

1 

Cooke G, Vera J (2018): 1068S epsis. In: Diagnosis and treatment in internal medicine. Oxford University Press.

2 

Rudd KE, Johnson SC, Agesa KM, et al. (2020): Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. 1474-547X (Electronic).

3 

Lazzaro A, De Girolamo G, Filippi V, et al. (2022): The interplay between host defense, infection, and clinical status in septic patients: A narrative review. Int J Mol Sci 2022; 23: 803.

4 

Knoop ST, Skrede S, Langeland N, Flaatten HK (2017): Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: A national retrospective study. PLoS One 12: e0187990.

5 

de Sousa ÁFL, Queiroz A, Oliveira LB, et al. (2017): Deaths among the elderly with ICU infections. Rev Bras Enferm 70: 733-739.

6 

Lee SH, Hsu TC, Lee MG, et al. (2018): Nationwide trend of sepsis: A comparison among octogenarians, elderly, and young adults. Crit Care Med 46: 926-934.

7 

Martin-Loeches I, Guia MC, Vallecoccia MS, et al. (2019): Risk factors for mortality in elderly and very elderly critically ill patients with sepsis: a prospective, observational, multicenter cohort study. Ann Intensive Care 9: 26.

8 

Martín S, Pérez A, Aldecoa C (2017): Sepsis and immunosenescence in the elderly patient: A review. Front Med (Lausanne) 4: 20.

9 

Vincent JL (2008): EPIC II: sepsis around the world. Minerva Anestesiol 74: 293-296.

10 

Cristina ML, Spagnolo AM, Giribone L, et al. (2021): Epidemiology and prevention of healthcare-associated infections in geriatric patients: A narrative review. Int J Environ Res Public Health 18: 5333.

11 

Ibarz M, Haas LEM, Ceccato A, Artigas A (2024): The critically ill older patient with sepsis: a narrative review. Ann Intensive Care 14: 6.

12 

Karcioglu O, Yilmaz S, Kılıç M, et al. (2022): Geriatric sepsis in the COVID-19 era: Challenges in diagnosis and management. Int J Pharma Res Allied Sci 11: 123-133.

13 

Simon L, Gauvin F, Amre DK, et al. (2004): Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39: 206-217.

14 

Takwoingi Y, Quinn TJ (2018): Review of diagnostic test accuracy (DTA) studies in older people. Age Ageing 47: 349-355.

15 

Sundvall PD, Elm M, Ulleryd P, et al. (2014): Interleukin-6 concentrations in the urine and dipstick analyses were related to bacteriuria but not symptoms in the elderly: a cross sectional study of 421 nursing home residents. BMC Geriatr 14: 88.

16 

He W, Xiao K, Fang M, Xie L (2021): Immune cell number, phenotype, and function in the elderly with sepsis. Aging Dis 12: 277-296.

17 

Lu X, Yang YM, Lu YQ (2022): Immunosenescence: A critical factor associated with organ injury after sepsis. Front Immunol 13: 917293.

18 

De Gaudio AR, Rinaldi S, Chelazzi C, Borracci T (2009): Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets 10: 60-70.

19 

Suzuki K, Inoue S, Kametani Y, et al. (2016): Reduced immunocompetent B cells and increased secondary infection in elderly patients with severe sepsis. Shock 46: 270-278.

20 

Gentile LF, Nacionales DC, Lopez MC, et al. (2014): Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol 192: 3156-3165.

21 

Wu J, Lu AD, Zhang LP, et al. (2019): Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 40: 52-57.

22 

Voets AJ, Tulner LR, Ligthart GJ (1997): Immunosenescence revisited. Does it have any clinical significance? Drugs Aging 11: 1-6.

23 

Shekarabi M, Asgari F (2014): Aging immunity and infection. In: Immunology of Aging. Massoud A, Rezaei N (Eds.). Springer Berlin Heidelberg, Berlin, Heidelberg; 231-238.

24 

Staats DO (2003): Aging, immunity and infection. Shock 20: 587.

25 

Fortin CF, McDonald PP, Lesur O, Fülöp T, Jr. (2008): Aging and neutrophils: there is still much to do. Rejuvenation Res 11: 873-882.

26 

Lord JM, Butcher S, Killampali V, et al. (2001): Neutrophil ageing and immunesenescence. Mech Ageing Dev 122: 1521-1535.

27 

Pastorek M, Konečná B, Janko J, et al. (2023): Mitochondria-induced formation of neutrophil extracellular traps is enhanced in the elderly via Toll-like receptor 9. J Leukoc Biol 114: 651-665.

28 

Fortin CF, Larbi A, Lesur O, et al. (2006): Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J Leukoc Biol 79: 1061-1072.

29 

Hinojosa E, Boyd AR, Orihuela CJ (2009): Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis 200: 546-554.

30 

Boyd AR, Shivshankar P, Jiang S, et al. (2012): Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. Exp Gerontol 47: 507-518.

31 

van Duin D, Mohanty S, Thomas V, et al. (2007): Age-associated defect in human TLR-1/2 function. J Immunol 178: 970-975.

32 

Li Z, Jiao Y, Fan EK, et al. (2017): Aging-impaired filamentous actin polymerization signaling reduces alveolar macrophage phagocytosis of bacteria. J Immunol 199: 3176-3186.

33 

Herrero C, Marqués L, Lloberas J, Celada A (2001): IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J Clin Invest 107: 485-493.

34 

Aprahamian T, Takemura Y, Goukassian D, Walsh K (2008): Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol 152: 448-455.

35 

Arnardottir HH, Dalli J, Colas RA, et al. (2014): Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. J Immunol 193: 4235-4244.

36 

Venet F, Monneret G (2018): Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14: 121-137.

37 

Nalos M, Santner-Nanan B, Parnell G, et al. (2012): Immune effects of interferon gamma in persistent staphylococcal sepsis. Am J Respir Crit Care Med 185: 110-112.

38 

Drossou-Agakidou V, Kanakoudi-Tsakalidou F, Sarafidis K, et al. (2002): In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates. Cytokine 18: 260-265.

39 

Le Garff-Tavernier M, Béziat V, Decocq J, et al. (2010): Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9: 527-535.

40 

Almeida-Oliveira A, Smith-Carvalho M, Porto LC, et al. (2011): Age-related changes in natural killer cell receptors from childhood through old age. Hum Immunol 72: 319-329.

41 

Müller L, Di Benedetto S, Pawelec G (2019): The immune system and its dysregulation with aging. Subcell Biochem 91: 21-43.

42 

Liu Z, Liang Q, Ren Y, et al. (2023): Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther 8: 200.

43 

Hazeldine J, Hampson P, Lord JM (2012): Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell 11: 751-759.

44 

Sagiv A, Biran A, Yon M, et al. (2013): Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 32: 1971-1977.

45 

Myśliwska J, Myśliwski A, Witkowski J (1985): Age-depen-dent decline of natural killer and antibody-dependent cell mediated cytotoxicity activity of human lymphocytes is connected with decrease of their acid phosphatase activity. Mech Ageing Dev 31: 1-11.

46 

Myśliwska J, Bigda J, Myśliwski A (1987): Activity of acid phosphatase in target binding cells expressing NK cytotoxic potential. Acta Histochem 82: 127-131.

47 

McVicar DW, Burshtyn DN (2001): Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci STKE 2001: re1.

48 

Agrawal A, Agrawal S, Gupta S (2007): Dendritic cells in human aging. Exp Gerontol 42: 421-426.

49 

Gupta S (2014): Role of dendritic cells in innate and adaptive immune response in human aging. Exp Gerontol 54: 47-52.

50 

Grolleau-Julius A, Harning EK, Abernathy LM, Yung RL (2008): Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res 68: 6341-6349.

51 

Kabashima K, Shiraishi N, Sugita K, et al. (2007): CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 171: 1249-1257.

52 

Agrawal A, Agrawal S, Cao J, et al. (2007): Aberrant innate immune functions of dendritic cells in aged humans. J Immunol 178: S120.

53 

Agrawal A, Agrawal S, Cao JN, et al. (2007): Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 178: 6912-6922.

54 

Panda A, Qian F, Mohanty S, et al. (2010): Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 184: 2518-2527.

55 

Agrawal S, Gollapudi S, Gupta S, Agrawal A (2013): Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to lithium chloride. Exp Gerontol 48: 1285-1292.

56 

Li G, Smithey MJ, Rudd BD, Nikolich-Žugich J (2012): Age-associated alterations in CD8α+ dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium. Aging Cell 11: 968-977.

57 

Ramoni D, Tirandi A, Montecucco F, Liberale L (2024): Sepsis in elderly patients: the role of neutrophils in pathophysiology and therapy. Intern Emerg Med 19: 901-917.

58 

Nacionales DC, Szpila B, Ungaro R, et al. (2015): A detailed characterization of the dysfunctional immunity and abnormal myelopoiesis induced by severe shock and trauma in the aged. J Immunol 195: 2396-2407.

59 

Demaret J, Venet F, Friggeri A, et al. (2015): Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol 98: 1081-1090.

60 

Tseng CW, Liu GY (2014): Expanding roles of neutrophils in aging hosts. Curr Opin Immunol 29: 43-48.

61 

Czaikoski PG, Mota JM, Nascimento DC, et al. (2016): Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS One 11: e0148142.

62 

Drew W, Wilson DV, Sapey E (2018): Inflammation and neutrophil immunosenescence in health and disease: Targeted treatments to improve clinical outcomes in the elderly. Exp Gerontol 105: 70-77.

63 

Pillay J, Kamp VM, van Hoffen E, et al. (2012): A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 122: 327-336.

64 

Kasten KR, Muenzer JT, Caldwell CC (2010): Neutrophils are significant producers of IL-10 during sepsis. Biochem Biophys Res Commun 393: 28-31.

65 

De Maeyer RPH, Chambers ES (2021): The impact of ageing on monocytes and macrophages. Immunol Lett 230: 1-10.

66 

Turnbull IR, Clark AT, Stromberg PE, et al. (2009): Effects of aging on the immunopathologic response to sepsis. Crit Care Med 37: 1018-1023.

67 

Rondina MT, Carlisle M, Fraughton T, et al. (2015): Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci 70: 225-231.

68 

Girard TD, Opal SM, Ely EW (2005): Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clin Infect Dis 40: 719-727.

69 

Leijte GP, Rimmelé T, Kox M, et al. (2020): Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes. Crit Care 24: 110.

70 

Venet F, Davin F, Guignant C, et al. (2010): Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34: 358-363.

71 

Sanchez-Correa B, Morgado S, Gayoso I, et al. (2011): Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother 60: 1195-1205.

72 

Wang Z, Guan D, Wang S, et al. (2020): Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions. Front Immunol 11: 202.

73 

Sheppard S, Santosa EK, Lau CM, et al. (2021): Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function. Cell Rep 35: 109210.

74 

Miranda D, Jara C, Mejias S, et al. (2018): Deficient mitochondrial biogenesis in IL-2 activated NK cells correlates with impaired PGC1-α upregulation in elderly humans. Exp Gerontol 110: 73-78.

75 

Chang CH, Curtis JD, Maggi LB, Jr., et al. (2013): Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153: 1239-1251.

76 

Griffiths HR, Yahia G (2018): Energy to fight infection. In: Handbook of Immunosenescence: Basic Understanding and Clinical Implications. Fulop T, Franceschi C, Hirokawa K, Pawelec G (Eds.). Springer International Publishing, Cham; 1-19.

77 

Ciaramella A, Spalletta G, Bizzoni F, et al. (2011): Effect of age on surface molecules and cytokine expression in human dendritic cells. Cell Immunol 269: 82-89.

78 

Umberger R, Callen B, Brown ML (2015): Severe sepsis in older adults. Crit Care Nurs Q 38: 259-270.

79 

Onawola AM (2021): Early recognition and management of sepsis in the elderly: A case study. Crit Care Nurs Q 44: 175-181.

80 

Lovászi M, Németh ZH, Pacher P, et al. (2022): A(2A) adenosine receptor activation prevents neutrophil aging and promotes polarization from N1 towards N2 phenotype. Purinergic Signal 18: 345-358.

81 

Sapey E, Patel JM, Greenwood H, et al. (2019): Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial. Am J Respir Crit Care Med 200: 1282-1293.

82 

Na YR, Gu GJ, Jung D, et al. (2016): GM-CSF induces inflammatory macrophages by regulating glycolysis and lipid metabolism. J Immunol 197: 4101-4109.

83 

Wessendarp M, Watanabe-Chailland M, Liu S, et al. (2022): Role of GM-CSF in regulating metabolism and mitochondrial functions critical to macrophage proliferation. Mitochondrion 62: 85-101.

84 

Assani K, Tazi MF, Amer AO, Kopp BT (2014): IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages. PLoS One 9: e96681.

85 

Anguille S, Lion E, Tel J, et al. (2012): Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential. PLoS One 7: e51851.

86 

Okada S, Han S, Patel ES, et al. (2015): STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells. Immunol Cell Biol 93: 461-471.

87 

Van Acker HH, Beretta O, Anguille S, et al. (2017): Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells. Oncotarget 8: 13652-13665.

88 

Zhang C, Zhang J, Niu J, et al. (2008): Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine 42: 128-136.

89 

Patil NK, Bohannon JK, Luan L, et al. (2017): Flt3 ligand treatment attenuates T cell dysfunction and improves survival in a murine model of burn wound sepsis. Shock 47: 40-51.

90 

Gill PS, Ozment TR, Lewis NH, et al. (2022): Trained immunity enhances human monocyte function in aging and sepsis. Front Immunol 13: 872652.

Copyright: © 2025 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.